empactica, Embrace, the future with the announcement of a groundbreaking collaboration.
Tomorrow is but Today’s Dream
Well not anymore it isn’t. The wearable tech industry has long been turning this famous quote by the author Khalil Gibran, on it’s head. More appropriate now would be Today’s dreams are last week’s history, and standby folks because things have only just started to get interesting!
Just spare a thought for those of us who are trying to keep ahead of this crazy niche, and keep you well informed of the development of the technology as it emerges. it really is becoming an impossible task.
I honestly thought when I started this blog that I, was going to be concentrating on bringing you in-depth product reviews, supplemented about once a month with a latest News article. How wrong was I?
Indeed, I have little doubt that as I am typing this up for you, I am slipping madly behind the next development announcement which obviously must be taking place right now, somewhere in the world. For example the release late last year of the astounding Embrace 2. Bloggers all over the place (even this morning I read an article) are still busy introducing it to the world, let alone actually doing a review of it. (Haha beat most of you there boys!). Well they need not waste their efforts, the horse has already bolted, with the announcement of a truly astounding collaboration put together with the sole intention of generating the next giant leap forward.
A Breathtaking Collaboration
A breathtaking collaboration, in more ways than one. Here is the announcement made on February 19th.
“Our team is very honored to support this ambitious project: it’s a great opportunity to produce novel science and products to potentially help millions of patients in the US and around the world. It is also a sign of inspired leadership by DRIVe’s team, with its deliberate vision to support technology at the service of better healthcare.” empactica CEO and co-founder, Matteo Lai.
For those who are not aware DRIVe, more correctly known as; BARDA Division of Research, Innovation and Ventures, is a major US Government department which itself is part of the HHS, Health and Human Services Div. So there you go folks if you wanted a slight pointer that something game-changing is afoot, there it is. And as far as little pointers go, this is about as substantial as they come.
So what’s going on?
Well as we know empactica, managed to squeeze an amazing amount of technology into the Embrace 2, that proved to be a game changing leap forward in both accuracy and reliability that it became the first wearable smart device to receive a HSS licence for seizure, alert. So much so that empactica, have immediately become recognised as a peerless world leader in such technology. The world-wide positive impact of this little device will only be capable of being measured in aeons, yet to come.
The plan, is a collaboration to lead towards the development of a new smartwatch device that will alert the wearer to the onset of symptoms leading towards serious respiratory infection before those symptoms are identifiable.
Moving forwards using freshly established standards
The recently FDA-approved Embrace 2, has established a new reality in the ability of innovative wearable technology to enable prompt preventative measures against serious, even life-threatening illness. In the case of asthma seizure, the Embrace 2 system is rapidly becoming the proffered method for this kind of prevention, not only in the US, but worldwide.
Discounting for a moment the possibilities of a specific global epidemic. The world-wide scale of community acquired respiratory disease is astronomical. In 2013, the latest available figures show 2.6 million deaths directly attributable to lower respiratory tract infections the 5th highest cause of premature deaths on the planet,and the leading cause of infectious death in children under the age of 5. Only heart disease and stroke claim more lives worldwide than acute respiratory disease.
As the vast majority of the world’s epidemics have historically been respiratory related it is hardly surprising that the general W.H.O prediction is that the likelihood is that the next epidemic will be a strain of influenza, is high. The possibility of a wearable device capable of early diagnosis and therefore the possibility of rapid response and treatment, could prove to save many lives.
“Imagine if your future smart watch could tell you your body is fighting sickness before you have any obvious symptoms— and that if you go to sleep two hours early tonight and drink a special beverage you would have 70% less chance of coming down with the flu tomorrow — how would your life be improved? Multiply that by 49M people in the U.S. who had influenza in 2018 — how would our world be improved? ” Empatica co-founder, chief scientist, and MITprofessor Rosalind Picard.
Although empatica, recognise the importance of initially targeting respiratory diagnosis their long term hope for the collaboration with DRIVe, is that their expertise can be used to recognise many other life threatening conditions. And ultimately save lives all over the world.
My site thrives on reader comment so please feel encouraged to leave your comment below.